Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
05 December 2014
Tuberculosis
South AfricaBrazilBRICSIndiaChina

BRICS countries must boost investments in research to defeat deadly drug-resistant tuberculosis crisis

4 min
Since July 2007, MSF has been running a kala azar diagnostic and treatment project in Vaishali district, in the centre of the Indian state of Bihar. Photograph by Anna Surinyach
Press release
Press release |
04 December 2014
HIV/AIDS Tropical & neglected diseases

Increased access to diagnosis and treatment of HIV-VL co-infection is imperative for eliminating kala azar

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi Photograph by Siddharth Singh
Press release
Press release |
03 December 2014
Intellectual property and trade
India

People Living With HIV Rally in Streets of Delhi as India Hosts RCEP Trade Negotiations

Press release |
01 December 2014
Intellectual property and trade Tropical & neglected diseases

Ebola To Be Added to List of Neglected Diseases Eligible for US government Research & Development Incentive

MSF nurse seen dispensing free medications and explaining patients how to take it at the MSF mobile clinic in Pusuguppa, which is a small village in AP along with border of Chhattisgarh. MSF mobile clinic provides free primary health care services which include diagnostic tests, vaccination, malaria and tuberculosis treatment, antenatal and postnatal consultations. Photograph by Sami Siva
Press release
Press release |
25 November 2014
Intellectual property and trade
India

As US Trade Representative Arrives in Delhi, MSF Urges India to Stand Strong Against Attack on Affordable Medicines

Press release |
25 November 2014
Intellectual property and trade

Patient Access to Miltefosine in Developing Countries Not Secure

“I want to get ARVs when I need them and not be at the clinic all the time even when I’m not sick” says Merjury Nyashanu from Zhenjeri village, Gutu district, Zimbabwe. Photograph by Munyaradzi Makari
Press release
Press release |
25 November 2014
HIV/AIDS

Beyond the rhetoric: implement proven community strategies to fight HIV/AIDS

MSF staff nurse seen administering drugs to Kala Azar patients in Sadar Hospital Hajipur. Photograph by Sami Siva
Press release
Press release |
17 November 2014
Tropical & neglected diseases
India

India: MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury